J Pathol Transl Med.  2018 May;52(3):202-205. 10.4132/jptm.2017.09.05.

Aberrant CD3 Expression in a Relapsed Plasma Cell Neoplasm

• Go JH

• KMID: 2412935
• DOI: http://doi.org/10.4132/jptm.2017.09.05

Abstract

No abstract available.

MeSH Terms

Neoplasms, Plasma Cell*
Plasma Cells*
Plasma*

Reference

1. Oliveira JL, Grogg KL, Macon WR, Dogan A, Feldman AL. Clinicopathologic features of B-cell lineage neoplasms with aberrant expression of CD3: a study of 21 cases. Am J Surg Pathol. 2012; 36:1364–70.

2. Spier CM, Grogan TM, Durie BG, et al. T-cell antigen-positive multiple myeloma. Mod Pathol. 1990; 3:302–7.

3. Tang YL, Chau CY, Yap WM, Chuah KL. CD3 expression in plasma cell neoplasm (multiple myeloma): a diagnostic pitfall. Pathology. 2012; 44:668–70.

4. Luo X, Kuklani R, Bains A. Dual CD3 and CD4 positive plasma cell neoplasm with indistinct morphology: a diagnostic pitfall. Pathology. 2016; 48:378–80.

5. Yagci M, Sucak GT, Akyol G, Haznedar R. Hepatic failure due to CD3+ plasma cell infiltration of the liver in multiple myeloma. Acta Haematol. 2002; 107:38–42.

6. Mishra P, Kakri S, Gujral S. Plasmablastic transformation of plasma cell myeloma with heterotropic expression of CD3 and CD4: a case report. Acta Clin Belg. 2017; 72:250–3.

7. Taddesse-Heath L, Meloni-Ehrig A, Scheerle J, Kelly JC, Jaffe ES. Plasmablastic lymphoma with MYC translocation: evidence for a common pathway in the generation of plasmablastic features. Mod Pathol. 2010; 23:991–9.

8. Vega F, Chang CC, Medeiros LJ, et al. Plasmablastic lymphomas and plasmablastic plasma cell myelomas have nearly identical immunophenotypic profiles. Mod Pathol. 2005; 18:806–15.

9. Sun J, Medeiros LJ, Lin P, Lu G, Bueso-Ramos CE, You MJ. Plasmablastic lymphoma involving the penis: a previously unreported location of a case with aberrant CD3 expression. Pathology. 2011; 43:54–7.

10. Gorczyca W. Atlas of differential diagnosis in neoplastic hematopathology. 3rd ed. Boca Raton: CRC Press;2014. p. 359–81.